{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T20:07:35Z","timestamp":1790712455475,"version":"4.1.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T00:00:00Z","timestamp":1786665600000},"content-version":"vor","delay-in-days":39,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Biohub https:\/\/biohub.org\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-75249-5","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T07:35:29Z","timestamp":1783323329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["AI-guided CRISPR screening reveals therapeutic targets in psoriasis"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2749-2899","authenticated-orcid":false,"given":"Chenlin","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mushaine","family":"Shih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharif","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amber","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-5778-0022","authenticated-orcid":false,"given":"Julia M.","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqi Jonathan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei-Ying","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason","family":"Perera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alanur","family":"Tutar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6414-1862","authenticated-orcid":false,"given":"Andrew","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0163-9290","authenticated-orcid":false,"given":"Ryan","family":"McClure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aly A.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3360-5359","authenticated-orcid":false,"given":"Shana O.","family":"Kelley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-2514-0173","authenticated-orcid":false,"given":"Abdalla M.","family":"Abdrabou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"75249_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-025-00630-5","volume":"11","author":"AW Armstrong","year":"2025","unstructured":"Armstrong, A. W. et al. Psoriasis. Nat. Rev. Dis. Primers 11, 45 (2025).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"75249_CR2","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1056\/NEJMra0804595","volume":"361","author":"FO Nestle","year":"2009","unstructured":"Nestle, F. O., Kaplan, D. H. & Barker, J. Psoriasis. N. Engl. J. Med. 361, 496\u2013509 (2009).","journal-title":"N. Engl. J. Med."},{"key":"75249_CR3","doi-asserted-by":"publisher","first-page":"754","DOI":"10.1016\/S0140-6736(21)00184-7","volume":"397","author":"K Ghoreschi","year":"2021","unstructured":"Ghoreschi, K., Balato, A., Enerb\u00e4ck, C. & Sabat, R. Therapeutics targeting the IL-23 and IL-17 pathway in psoriasis. Lancet 397, 754\u2013766 (2021).","journal-title":"Lancet"},{"key":"75249_CR4","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1001\/jama.2020.4006","volume":"323","author":"AW Armstrong","year":"2020","unstructured":"Armstrong, A. W. & Read, C. Pathophysiology, clinical presentation, and treatment of psoriasis: a review. JAMA 323, 1945\u20131960 (2020).","journal-title":"JAMA"},{"key":"75249_CR5","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/jid.2014.295","volume":"135","author":"D Jullien","year":"2015","unstructured":"Jullien, D., Prinz, J. C. & Nestle, F. O. Immunogenicity of biotherapy used in psoriasis: the science behind the scenes. J. Investig. Dermatol. 135, 31\u201338 (2015).","journal-title":"J. Investig. Dermatol."},{"key":"75249_CR6","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s40264-015-0287-7","volume":"38","author":"L Barnes","year":"2015","unstructured":"Barnes, L., Kaya, G. & Rollason, V. Topical corticosteroid-induced skin atrophy: a comprehensive review. Drug Saf. 38, 493\u2013509 (2015).","journal-title":"Drug Saf."},{"key":"75249_CR7","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1038\/s43586-021-00093-4","volume":"2","author":"C Bock","year":"2022","unstructured":"Bock, C. et al. High-content CRISPR screening. Nat. Rev. Methods Primers 2, 8 (2022).","journal-title":"Nat. Rev. Methods Primers"},{"key":"75249_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adq8122","volume":"10","author":"AM Abdrabou","year":"2024","unstructured":"Abdrabou, A. M. et al. Identification of VISTA regulators in macrophages mediating cancer cell survival. Sci. Adv. 10, eadq8122 (2024).","journal-title":"Sci. Adv."},{"key":"75249_CR9","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1021\/acschembio.8b00260","volume":"14","author":"PF Slivka","year":"2019","unstructured":"Slivka, P. F. et al. Small molecule and pooled CRISPR screens investigating IL17 signaling identify BRD2 as a novel contributor to keratinocyte inflammatory responses. ACS Chem. Biol. 14, 857\u2013872 (2019).","journal-title":"ACS Chem. Biol."},{"key":"75249_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-025-07691-0","volume":"16","author":"B Cheng","year":"2025","unstructured":"Cheng, B. et al. Comprehensive secretome profiling and CRISPR screen identifies SFRP1 as a key inhibitor of epidermal progenitor proliferation. Cell Death Dis. 16, 360 (2025).","journal-title":"Cell Death Dis."},{"key":"75249_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14744","volume":"8","author":"G Walko","year":"2017","unstructured":"Walko, G. et al. A genome-wide screen identifies YAP\/WBP2 interplay conferring growth advantage on human epidermal stem cells. Nat. Commun. 8, 14744 (2017).","journal-title":"Nat. Commun."},{"key":"75249_CR12","doi-asserted-by":"crossref","unstructured":"Song, S. et al. Virtual CRISPR: Can LLMs predict CRISPR screen results? In Proc. 24th Workshop on Biomedical Language Processing 354\u2013364 (Association for Computational Linguistics, Viena, Austria, 2025).","DOI":"10.18653\/v1\/2025.bionlp-1.30"},{"key":"75249_CR13","doi-asserted-by":"publisher","first-page":"100082","DOI":"10.1016\/j.xjidi.2021.100082","volume":"2","author":"JPH Smits","year":"2022","unstructured":"Smits, J. P. H. et al. CRISPR-Cas9-based genomic engineering in keratinocytes: from technology to application. JID Innov. 2, 100082 (2022).","journal-title":"JID Innov."},{"key":"75249_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-59503-w","volume":"16","author":"AB Mihalas","year":"2025","unstructured":"Mihalas, A. B. et al. KAT5 regulates neurodevelopmental states associated with G0-like populations in glioblastoma. Nat. Commun. 16, 4327 (2025).","journal-title":"Nat. Commun."},{"key":"75249_CR15","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.ydbio.2022.09.008","volume":"492","author":"S Mohammadparast","year":"2022","unstructured":"Mohammadparast, S. & Chang, C. Ash2l, an obligatory component of H3K4 methylation complexes, regulates neural crest development. Dev. Biol. 492, 14\u201324 (2022).","journal-title":"Dev. Biol."},{"key":"75249_CR16","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1038\/ng.313","volume":"41","author":"R De Cid","year":"2009","unstructured":"De Cid, R. et al. Deletion of the late cornified envelope LCE3B and LCE3C genes as a susceptibility factor for psoriasis. Nat. Genet. 41, 211\u2013215 (2009).","journal-title":"Nat. Genet."},{"key":"75249_CR17","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1159\/000535362","volume":"114","author":"S Hidema","year":"2024","unstructured":"Hidema, S. et al. Oxytocin receptor-expressing neurons in the medial preoptic area are essential for lactation, whereas those in the lateral septum are not critical for maternal behavior. Neuroendocrinology 114, 517\u2013537 (2024).","journal-title":"Neuroendocrinology"},{"key":"75249_CR18","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-023-04804-1","volume":"21","author":"J Chen","year":"2023","unstructured":"Chen, J. et al. ALOX5 acts as a key role in regulating the immune microenvironment in intrahepatic cholangiocarcinoma, recruiting tumor-associated macrophages through PI3K pathway. J. Transl. Med. 21, 923 (2023).","journal-title":"J. Transl. Med."},{"key":"75249_CR19","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1038\/jhh.2013.67","volume":"28","author":"Y-P Zhang","year":"2014","unstructured":"Zhang, Y.-P. et al. CYP3A5 polymorphism, amlodipine and hypertension. J. Hum. Hypertens. 28, 145\u2013149 (2014).","journal-title":"J. Hum. Hypertens."},{"key":"75249_CR20","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.142067","volume":"5","author":"Y Jiang","year":"2020","unstructured":"Jiang, Y. et al. Cytokinocytes: the diverse contribution of keratinocytes to immune responses in skin. JCI Insight 5, e142067 (2020).","journal-title":"JCI Insight"},{"key":"75249_CR21","doi-asserted-by":"publisher","first-page":"109940","DOI":"10.1016\/j.isci.2024.109940","volume":"27","author":"R Sugisawa","year":"2024","unstructured":"Sugisawa, R., Shanahan, K. A., Davis, G. M., Davey, G. P. & Bowie, A. G. SARM1 regulates pro-inflammatory cytokine expression in human monocytes by NADase-dependent and -independent mechanisms. iScience 27, 109940 (2024).","journal-title":"iScience"},{"key":"75249_CR22","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.3390\/ijms22105124","volume":"22","author":"A Kulawik-Pi\u00f3ro","year":"2021","unstructured":"Kulawik-Pi\u00f3ro, A. & Miastkowska, M. Polymeric gels and their application in the treatment of psoriasis vulgaris: a review. Int. J. Mol. Sci. 22, 5124 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"75249_CR23","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L Van Der Fits","year":"2009","unstructured":"Van Der Fits, L. et al. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. J. Immunol. 182, 5836\u20135845 (2009).","journal-title":"J. Immunol."},{"key":"75249_CR24","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.ade5915","volume":"16","author":"CG M\u00e5rten","year":"2024","unstructured":"M\u00e5rten, C. G., Winge et al. Repurposing an epithelial sodium channel inhibitor as a therapy for murine and human skin inflammation. Sci.Transl. Med. 16, eade5915 (2024).","journal-title":"Sci.Transl. Med."},{"key":"75249_CR25","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1007\/s12016-018-8702-3","volume":"55","author":"A Blauvelt","year":"2018","unstructured":"Blauvelt, A. & Chiricozzi, A. The immunologic role of IL-17 in psoriasis and psoriatic arthritis pathogenesis. Clin. Rev. Allergy Immunol. 55, 379\u2013390 (2018).","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"75249_CR26","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1111\/exd.12710","volume":"24","author":"K Reich","year":"2015","unstructured":"Reich, K. et al. Evidence that a neutrophil\u2013keratinocyte crosstalk is an early target of IL -17A inhibition in psoriasis. Exp. Dermatol. 24, 529\u2013535 (2015).","journal-title":"Exp. Dermatol."},{"key":"75249_CR27","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1016\/j.jid.2020.07.028","volume":"141","author":"J Chen","year":"2021","unstructured":"Chen, J. et al. Neutrophils enhance cutaneous vascular dilation and permeability to aggravate psoriasis by releasing matrix metallopeptidase 9. J. Investig. Dermatol. 141, 787\u2013799 (2021).","journal-title":"J. Investig. Dermatol."},{"key":"75249_CR28","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202402016","volume":"223","author":"J Li","year":"2024","unstructured":"Li, J. et al. LYSMD proteins promote activation of Rab32-family GTPases for lysosome-related organelle biogenesis. J. Cell Biol. 223, e202402016 (2024).","journal-title":"J. Cell Biol."},{"key":"75249_CR29","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1242\/jcs.01723","volume":"118","author":"E Loh","year":"2005","unstructured":"Loh, E., Peter, F., Subramaniam, V. N. & Hong, W. Mammalian Bet3 functions as a cytosolic factor participating in transport from the ER to the Golgi apparatus. J. Cell Sci. 118, 1209\u20131222 (2005).","journal-title":"J. Cell Sci."},{"key":"75249_CR30","doi-asserted-by":"publisher","first-page":"1124786","DOI":"10.3389\/fimmu.2023.1124786","volume":"14","author":"L Luo","year":"2023","unstructured":"Luo, L., Guo, Y., Chen, L., Zhu, J. & Li, C. Crosstalk between cholesterol metabolism and psoriatic inflammation. Front. Immunol. 14, 1124786 (2023).","journal-title":"Front. Immunol."},{"key":"75249_CR31","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1038\/nature04398","volume":"438","author":"S McLaughlin","year":"2005","unstructured":"McLaughlin, S. & Murray, D. Plasma membrane phosphoinositide organization by protein electrostatics. Nature 438, 605\u2013611 (2005).","journal-title":"Nature"},{"key":"75249_CR32","doi-asserted-by":"publisher","first-page":"2205","DOI":"10.1101\/gad.1102703","volume":"17","author":"PG Hogan","year":"2003","unstructured":"Hogan, P. G., Chen, L., Nardone, J. & Rao, A. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17, 2205\u20132232 (2003).","journal-title":"Genes Dev."},{"key":"75249_CR33","doi-asserted-by":"publisher","first-page":"2476","DOI":"10.1038\/sj.onc.1204386","volume":"20","author":"F Maci\u00e1n","year":"2001","unstructured":"Maci\u00e1n, F., L\u00f3pez-Rodr\u00edguez, C. & Rao, A. Partners in transcription: NFAT and AP-1. Oncogene 20, 2476\u20132489 (2001).","journal-title":"Oncogene"},{"key":"75249_CR34","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.jid.2021.08.430","volume":"142","author":"Y Yu","year":"2022","unstructured":"Yu, Y. et al. Cytosolic DNA-mediated STING-dependent inflammation contributes to the progression of psoriasis. J. Investig. Dermatol. 142, 898\u2013906.e4 (2022).","journal-title":"J. Investig. Dermatol."},{"key":"75249_CR35","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.it.2018.01.007","volume":"39","author":"Y Cui","year":"2018","unstructured":"Cui, Y. & Le, Y. Formyl-peptide receptors in infection, inflammation, and cancer. Trends Immunol. 39, 302\u2013315 (2018).","journal-title":"Trends Immunol."},{"key":"75249_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1038\/s41392-023-01655-6","volume":"8","author":"J Guo","year":"2023","unstructured":"Guo, J. et al. Signaling pathways and targeted therapies for psoriasis. Signal Transduct. Target. Ther. 8, 437 (2023).","journal-title":"Signal Transduct. Target. Ther."},{"key":"75249_CR37","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1111\/j.1600-0625.2012.01472.x","volume":"21","author":"M Kypriotou","year":"2012","unstructured":"Kypriotou, M., Huber, M. & Hohl, D. The human epidermal differentiation complex: cornified envelope precursors, S100 proteins and the \u2018fused genes\u2019 family. Exp. Dermatol. 21, 643\u2013649 (2012).","journal-title":"Exp. Dermatol."},{"key":"75249_CR38","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1046\/j.1365-2249.2002.01721.x","volume":"127","author":"A Koreck","year":"2002","unstructured":"Koreck, A. et al. CD3+CD56+ NK T cells are significantly decreased in the peripheral blood of patients with psoriasis. Clin. Exp. Immunol. 127, 176\u2013182 (2002).","journal-title":"Clin. Exp. Immunol."},{"key":"75249_CR39","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1111\/jdv.13269","volume":"30","author":"D Wilsmann-Theis","year":"2016","unstructured":"Wilsmann-Theis, D. et al. Among the S100 proteins, S100A12 is the most significant marker for psoriasis disease activity. J. Eur. Acad. Dermatol. Venereol. 30, 1165\u20131170 (2016).","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"75249_CR40","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1056\/NEJMp038190","volume":"350","author":"R De Caterina","year":"2004","unstructured":"De Caterina, R. & Zampolli, A. From asthma to atherosclerosis\u20145-lipoxygenase, leukotrienes, and inflammation. N. Engl. J. Med. 350, 4\u20137 (2004).","journal-title":"N. Engl. J. Med."},{"key":"75249_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2011\/350546","volume":"2011","author":"N Vrachnis","year":"2011","unstructured":"Vrachnis, N., Malamas, F. M., Sifakis, S., Deligeoroglou, E. & Iliodromiti, Z. The oxytocin-oxytocin receptor system and its antagonists as tocolytic agents. Int. J. Endocrinol. 2011, 1\u20138 (2011).","journal-title":"Int. J. Endocrinol."},{"key":"75249_CR42","doi-asserted-by":"publisher","DOI":"10.1126\/science.abj4008","volume":"375","author":"R Schmidt","year":"2022","unstructured":"Schmidt, R. et al. CRISPR activation and interference screens decode stimulation responses in primary human T cells. Science 375, eabj4008 (2022).","journal-title":"Science"},{"key":"75249_CR43","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0554-4","volume":"15","author":"W Li","year":"2014","unstructured":"Li, W. et al. MAGeCK enables robust identification of essential genes from genome-scale CRISPR\/Cas9 knockout screens. Genome Biol. 15, 554 (2014).","journal-title":"Genome Biol."},{"key":"75249_CR44","doi-asserted-by":"publisher","first-page":"2719","DOI":"10.1534\/g3.117.041277","volume":"7","author":"T Hart","year":"2017","unstructured":"Hart, T. et al. Evaluation and design of genome-wide CRISPR\/SpCas9 knockout screens. G3. 7, 2719\u20132727 (2017).","journal-title":"G3"},{"key":"75249_CR45","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12865-021-00401-3","volume":"22","author":"Q Li","year":"2021","unstructured":"Li, Q., Liu, W., Gao, S., Mao, Y. & Xin, Y. Application of imiquimod-induced murine psoriasis model in evaluating interleukin-17A antagonist. BMC Immunol. 22, 11 (2021).","journal-title":"BMC Immunol."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75249-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75249-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75249-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T22:30:46Z","timestamp":1786660246000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-75249-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["75249"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-75249-5","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"4 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A.A.K., S.O.K., and A.M.A. have submitted a provisional patent application to the US Patent Office pertaining to the methods and findings described in this work (application number 63\/944,804). The remaining authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"8346"}}